BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14135805)

  • 1. [IMPORTANCE OF THE THROMBOTEST. II. A COMPARATIVE STUDY OF THE THROMBOTEST, THROMBOPLASTIN TIME AND PARTIAL THROMBOPLASTIN TIME].
    FREDERIKS PW
    Ned Tijdschr Geneeskd; 1964 Jan; 108():156-61. PubMed ID: 14135805
    [No Abstract]   [Full Text] [Related]  

  • 2. THROMBOTEST REAGENT AND CHRISTMAS DISEASE.
    VERMYLEN C; VERSTRAETE M; VORLAT M
    Lancet; 1964 Mar; 1(7332):565-6. PubMed ID: 14103602
    [No Abstract]   [Full Text] [Related]  

  • 3. LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.
    SHAW S; PEGRUM GD; WOLFF S
    J Clin Pathol; 1965 May; 18(3):327-9. PubMed ID: 14304246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M; TANAKA M
    Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
    [No Abstract]   [Full Text] [Related]  

  • 5. BLOOD COAGULATION. VII. COAGULATION II.
    DUGDALE M
    Memphis Mid South Med J; 1963 Jan; 38():19-22. PubMed ID: 14087826
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
    Hjorth B; Kjaersgaard E
    Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
    DOKU HC; TAYLOR RG; SISE HS; BECKER R
    J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
    [No Abstract]   [Full Text] [Related]  

  • 8. AN ASSESSMENT OF ANTICOAGULANT THERAPY AND COMPARISON OF QUICK TEST, THROMBOTEST AND 2.7.10 REAGENTS.
    TAYLOR DM; STENBECK CL; ERENSTROM AJ
    N Z Med J; 1965 Jan; 64():29-34. PubMed ID: 14257136
    [No Abstract]   [Full Text] [Related]  

  • 9. [TRIALS ON THE CAPILLARY BLOOD METHOD FOR THE CONTROL OF ANTICOAGULANT THERAPY: THE OWREN THROMBOTEST AND HARTERT PROTHROMBIN TIME].
    FISCHER M
    Thromb Diath Haemorrh; 1964 Apr; 11():243-53. PubMed ID: 14167109
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 11. MODIFICATIONS OF THE COAGULATION MECHANISM DURING PREGNANCY.
    PHILLIPS LL
    Mod Trends Hum Reprod Physiol; 1963; 15():190-204. PubMed ID: 14115154
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of a recombinant thromboplastin with Thrombotest for oral anticoagulant control.
    Baele G; Fiers T; Leroux-Roels G
    Haemostasis; 1996; 26(1):11-5. PubMed ID: 8698273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE THROMBOTEST REAGENT AND CHRISTMAS DISEASE.
    KIDD P; DENSON KW; BIGGS R
    Lancet; 1963 Sep; 2(7306):522. PubMed ID: 14065429
    [No Abstract]   [Full Text] [Related]  

  • 15. EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS.
    POLLER L; THOMSON J
    Lancet; 1964 Jul; 2(7350):62-4. PubMed ID: 14158680
    [No Abstract]   [Full Text] [Related]  

  • 16. ANTICOAGULANT THERAPY--BOON OR BANE?
    CELANDER DR; CELANDER E; MARTIN CG
    J Am Osteopath Assoc; 1964 Dec; 64():359-65. PubMed ID: 14233113
    [No Abstract]   [Full Text] [Related]  

  • 17. [STUDIES ON FACTOR IX ACTIVITY. I. RELATION BETWEEN SERUM THROMBOPLASTIN GENERATION TEST AND WHOLE BLOOD CLOTTING TIME, WITH SPECIAL REFERENCE TO THE MODE OF ACTION OF FACTOR IX AND CONTACT FACTOR].
    MATSUOKA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Apr; 26():231-43. PubMed ID: 14043489
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. I. The Quick one-stage procedure, the prothrombin and proconvertin test and the one-stage determination of true prothrombin activity.
    RODMAN T; PASTOR BH; FAWCETT KC
    Am J Med; 1961 Oct; 31():547-54. PubMed ID: 14493137
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VII Padua 1. Another case.
    Croze M; Brizard CP
    Haemostasis; 1982; 11(3):185-8. PubMed ID: 7095606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    IAROSHEVSKII AIa; ZHAVORONKOVA EK
    Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.